On Monday, President Donald Trump said during a press conference that he had been taking the anti-malarial drug hydroxychloroquine as unproven protection against COVID-19. The fallout has left health experts scrambling again to explain that the drug has not been shown to work against the novel coronavirus — and that it can have dangerous side effects.
While the drug is approved by the FDA for certain illnesses such as malaria, lupus, and rheumatoid arthritis, Dr. Leana Wen, an emergency physician and visiting public health professor at George Washington University, told Cheddar that only patients with those particular diseases or those in approved clinical trials for COVID-19 should be on the controversial treatment.
"We have to remember that this medication, just like all others, has potential side effects," Dr. Wen said. The physician listed potential reactions including psychosis, hallucinations, liver damage, heart damage, and even death from cardiac arrhythmia (an abnormal heart rhythm).
She also noted that, while Trump's age and medical history put him in the demographic most vulnerable to COVID-19 and among those who may need to worry about the cardiac effect of the drug, he has still had interactions with people who have tested positive for the virus. That could have led to White House physician Dr. Sean Conley signing off on the course of treatment he alluded to in a statement to the press, said Wen, although she questioned some of the other prevention choices the president and his administration have made. "If they are so concerned that he had exposure to COVID-19, why is he still around so many people wearing no mask, and instead of being in quarantine?"
"What the president is saying is, frankly, irresponsible because there are many people around the country for whom he is the most credible messenger," Wen said. "I really fear that they're now going to go out and ask their doctors for hydroxychloroquine."
According to the doctor, after previous statements by the president regarding the anti-malaria treatment, prescriptions greatly increased around the nation. The run on the drug made it difficult for patients with conditions like lupus and arthritis to acquire necessary prescriptions.
"I just really worry that there could be real harm to patients across the country and that some patients may get the false reassurance. They may think that this drug may prevent them from getting COVID-19 when that is not proven in way, shape, or form," she said.
Wen pleaded for people to listen to medical professionals and to avoid taking advice from "non-doctors." With no confirmed treatment or vaccine, she emphasized that wearing masks, social distancing, and good hand and face hygiene are still the best ways to defend against the novel coronavirus.
"This is a time in a pandemic when there is so much misinformation, inaccurate information," she stated. "And we need the president of our country to be standing up and debunking these myths, not adding to them."
A new report finds the Department of Government Efficiency’s remaking of the federal workforce has battered the Washington job market and put more households in the metropolitan area in financial distress.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Federal Reserve Chair Jerome Powell on Tuesday signaled a cautious approach to future interest rate cuts, in sharp contrast with other Fed officials who have called for a more urgent approach. In remarks in Providence, Rhode Island, Powell noted that there are risks to both of the Fed’s goals of seeking maximum employment and stable prices. His approach is in sharp contrast to some members of the Fed’s rate-setting committee who are pushing for faster cuts.
President Donald Trump’s efforts to reshape the American media landscape have led to the suspension of late-night comedian Jimmy Kimmel.
Ben & Jerry’s co-founder Jerry Greenfield is leaving the ice cream brand after 47 years. He says the freedom the company used to have to speak up on social issues has been stifled
The Federal Reserve cut its key interest rate by a quarter-point Wednesday and projected it would do so twice more this year as concern grows at the central bank about the health of the nation’s labor market. The move is the Fed’s first cut since December and lowered its short-term rate to about 4.1%, down from 4.3%. Fed officials, led by Chair Jerome Powell, had kept their rate unchanged this year as they evaluated the impact of tariffs, tighter immigration enforcement, and other Trump administration policies on inflation and the economy. The only dissenter was Stephen Miran, the recent Trump-appointee.
After a late-night vote and last-minute ruling, the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.
The Trump administration has issued its first warnings to online services that offer unofficial versions of popular drugs like the blockbuster obesity treatment Wegovy.
Albania's Prime Minister Edi Rama says his new Cabinet will include an artificial intelligence “minister” in charge of fighting corruption. The AI, named Diella, will oversee public funding projects and combat corruption in public tenders. Diella was launched earlier this year as a virtual assistant on the government's public service platform. Corruption has been a persistent issue in Albania since 1990. Rama's Socialist Party won a fourth consecutive term in May. It aims to deliver EU membership for Albania in five years, but the opposition Democratic Party remains skeptical.
